Clinic
Saint Alphonsus Medical Center- Ontario INC
Saint Alphonsus Medical Center- Ontario INC was paid $3.67M by Medicaid between Jan 2018 and Nov 2024, across 94 billing codes. Its largest line is 99283, emergency room visit (moderate) — 47% of everything it billed.
33Billing provider infoSAINT ALPHONSUS MEDICAL CENTER- ONTARIO INC
ONTARIO, OR 97914
ONTARIO, OR 97914
33aNPI1891891792assigned 09/16/2006
33bProvider typeRehabilitation Clinic/Center
28Total paid$3.67M
24GClaims84,642
24DCodes billed94
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Rehabilitation Clinic/Center providers in Oregon
Rank by total paid#1 of 9
Median peer was paid$85K
This provider vs. median43×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official CHECKETTS, BRIAN controls 13+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 21,242 | $562K | |
| 2019 | 14,101 | $408K | |
| 2020 | 10,128 | $448K | |
| 2021 | 7,652 | $536K | |
| 2022 | 12,919 | $741K | |
| 2023 | 9,726 | $509K | |
| 2024incomplete | 8,874 | $464K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 47% | 8,711 | 8,093 | $1.73M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 22% | 2,790 | 2,467 | $807K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.2% | 1,135 | 1,067 | $116K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.9% | 1,294 | 1,125 | $106K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2.6% | 264 | 234 | $95K |
| 41899 | Unlisted procedure, dentoalveolar structures | 2.4% | 44 | 44 | $87K |
| 80053 | Comprehensive metabolic panel | 1.9% | 12,600 | 10,660 | $69K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.7% | 1,424 | 431 | $61K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.5% | 13,697 | 11,587 | $56K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 1.4% | 4,180 | 1,871 | $53K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.2% | 844 | 696 | $42K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 543 | 525 | $32K |
82 more codes
| 71045 | Radiologic examination, chest; single view | <1% | 1,128 | $30K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 297 | $28K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 128 | $27K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 362 | $27K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 893 | $24K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 893 | $24K |
| 36415 | Collection of venous blood by venipuncture | <1% | 9,926 | $24K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,281 | $20K |
| 87481 | <1% | 418 | $17K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 421 | $12K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 324 | $12K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,644 | $10K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 155 | $10K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 318 | $9K |
| 87511 | <1% | 401 | $9K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 387 | $8K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 103 | $6K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 489 | $6K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 95 | $6K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 489 | $6K |
| 83690 | <1% | 1,161 | $5K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 176 | $5K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 693 | $5K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 196 | $4K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 203 | $4K |
| 97602 | <1% | 68 | $4K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 613 | $3K |
| 84484 | <1% | 693 | $3K | |
| 87070 | <1% | 414 | $3K | |
| 81001 | <1% | 1,413 | $3K | |
| 86696 | <1% | 190 | $3K | |
| 87660 | <1% | 175 | $3K | |
| 86747 | <1% | 222 | $3K | |
| 86850 | <1% | 284 | $3K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 41 | $2K |
| 86787 | <1% | 225 | $2K | |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | <1% | 26 | $2K |
| J2704 | Injection, propofol, 10 mg | <1% | 633 | $2K |
| 84439 | <1% | 299 | $2K | |
| 86694 | <1% | 190 | $2K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 108 | $2K |
| 85027 | <1% | 398 | $2K | |
| 86695 | <1% | 190 | $2K | |
| 80061 | Lipid panel | <1% | 231 | $2K |
| 87340 | <1% | 215 | $2K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 40 | $2K |
| 81003 | <1% | 954 | $2K | |
| 86762 | <1% | 131 | $2K | |
| 86780 | <1% | 178 | $2K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 601 | $1K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 973 | $1K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 28 | $1K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,554 | $1K |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 491 | $1K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 611 | $922.88 |
| 87077 | <1% | 101 | $874.20 | |
| 97162 | <1% | 14 | $783.27 | |
| 86900 | <1% | 276 | $719.00 | |
| 86901 | <1% | 273 | $712.36 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 33 | $712.24 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 26 | $692.92 |
| 85610 | <1% | 290 | $680.87 | |
| 81025 | <1% | 109 | $667.62 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 339 | $631.59 |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 42 | $596.16 |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 110 | $507.15 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 44 | $461.18 |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 97 | $430.50 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 155 | $386.43 |
| 82248 | <1% | 80 | $258.50 | |
| 84702 | <1% | 13 | $217.49 | |
| 84703 | <1% | 27 | $183.92 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 124 | $169.84 |
| 87081 | <1% | 24 | $144.00 | |
| 85730 | <1% | 27 | $139.38 | |
| 82950 | <1% | 30 | $117.26 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 14 | $94.24 |
| 86140 | <1% | 12 | $53.46 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 46 | $49.50 |
| 83735 | <1% | 13 | $44.11 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 14 | $26.17 |
| 11721 | <1% | 13 | $0.17 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCHECKETTS, BRIAN (CFO)
| Provider | Location | Paid |
|---|---|---|
| Saint Alphonsus Regional Medical Center INC | Caldwell, ID | $32.60M |
| Saint Alphonsus Regional Medical Center INC | Caldwell, ID | $9.83M |
| Saint Alphonsus Regional Medical Center INC | Boise, ID | $5.08M |
| Saint Alphonsus Medical Center Baker City, INC | Baker City, OR | $4.31M |
| Saint Alphonsus Regional Medical Center INC | Boise, ID | $4.17M |
| Saint Alphonsus Regional Medical Center INC | Boise, ID | $1.92M |
| Saint Alphonsus Medical Center- Ontario INC | Fruitland, ID | $856K |
| Saint Alphonsus Medical Center- Ontario INC | Ontario, OR | $753K |
| ST Alphonsus Professional Medical Services LLC | Boise, ID | $408K |
| Saint Alphonsus Medical Center Baker City, INC | Baker City, OR | $342K |
| Saint Alphonsus Regional Medical Center INC | Boise, ID | $295K |
| Saint Alphonsus Medical Center Baker City, INC. | Baker City, OR | $223K |
| Saint Alphonsus Medical Center- Ontario INC | Ontario, OR | $6K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.